ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve

ClinicalTrials.gov ID: NCT05526560

Public ClinicalTrials.gov record NCT05526560. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Global Study Designed to Collect Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve

Study identification

NCT ID
NCT05526560
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Edwards Lifesciences
Industry
Enrollment
504 participants

Conditions and interventions

Interventions

  • MITRIS RESILIA Mitral Valve, Model 11400M Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 10, 2023
Primary completion
Dec 31, 2027
Completion
Nov 30, 2035
Last update posted
Apr 13, 2026

2023 – 2035

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
Hoag Memorial Hospital Presbyterian Newport Beach California 92663
Stanford University Palo Alto California 94305
AdventHealth Orlando Orlando Florida 32803
Piedmont Heart Institute Athens Georgia 30606
Piedmont Heart Institute Atlanta Georgia 30309
Ascension St. Vincent Heart Center Carmel Indiana 46290
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic, Rochester Rochester Minnesota 55905
Washington University Barnes-Jewish Hospital St Louis Missouri 63110
Mount Sinai Hospital New York New York 10029
Columbia University Irving Medical Center New York New York 10032
Weill Cornell Medicine New York New York 10065
Duke University Medical Center Durham North Carolina 27703
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Allegheny General Hospital Pittsburgh Pennsylvania 15212
UPMC Presbyterian Shadyside Pittsburgh Pennsylvania 15232
Tristar Centennial Medical Center Nashville Tennessee 37203
Ascension Saint Thomas Nashville Tennessee 37205
University of Utah Salt Lake City Utah 84112
Aurora St. Luke's Medical Center Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05526560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05526560 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →